Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.3K Sell
145
-77
-35% -$10.1K ﹤0.01% 1588
2025
Q4
$30.2K Buy
222
+218
+5,450% +$31.4K ﹤0.01% 1347
2025
Q3
$590 Hold
4
﹤0.01% 1813
2025
Q2
$517 Sell
4
-96
-96% -$11.6K ﹤0.01% 1826
2025
Q1
$11.9K Sell
100
-16
-14% -$1.98K ﹤0.01% 1295
2024
Q4
$13.5K Sell
116
-36
-24% -$4.55K ﹤0.01% 1285
2024
Q3
$20.5K Buy
152
+2
+1% +$268 ﹤0.01% 1193
2024
Q2
$20.3K Buy
+150
New +$20.4K ﹤0.01% 1155
2023
Q4
Sell
-1,000
Closed -$91K 1848
2023
Q3
$91K Hold
1,000
﹤0.01% 797
2023
Q2
$113K Buy
+1,000
New +$106K ﹤0.01% 758
2018
Q4
Sell
-2,000
Closed -$160K 1207
2018
Q3
$160K Buy
+2,000
New +$149K 0.01% 681
2017
Q1
Sell
-300
Closed -$15K 1092
2016
Q4
$15K Buy
+300
New +$15.2K ﹤0.01% 993

Other funds holding XYL

Ancora Advisors's XYL Position: Q1 2026 in Review

Ancora Advisors reduced its Xylem (XYL) stake by 35% in Q1 2026, selling an estimated $10.1K and leaving 145 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

Ancora Advisors first reported a position in XYL in Q4 2016 and has held it in 12 quarters since. The position peaked at $160K in Q3 2018. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Ancora Advisors held 145 shares of Xylem worth $17.3K as of Q1 2026.
  • Ancora Advisors sold 77 Xylem shares in Q1 2026, an estimated $10.1K.
  • Xylem made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1588 holding.
  • Ancora Advisors first reported a position in Xylem in Q4 2016 and has held it in 12 quarters since.
  • Ancora Advisors's Xylem position peaked at $160K in Q3 2018.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.